Grapefruit

As little as one whole grapefruit or 7 ounces of grapefruit juice is sufficient to produce significant drug toxicity. Many prescription drug labels explicitly warn against grapefruit consumption. Grapefruit CYP3A4 inhibition affects statins used for cholesterol reduction. Grapefruit CYP3A4 inhibition affects calcium channel blockers used for blood pressure. Grapefruit contains a chemical compound that inhibits the CYP3A4 liver enzymes responsible for metabolizing certain medications. Grapefruit contains compounds that specifically inhibit cytochrome P450 enzymes. Grapefruit inhibits enzymes that break down cortisol. Grapefruit prolongs cortisol activity rather than directly increasing cortisol production. Grapefruit is sliced and paired with chia seeds as a fresh fruit component of the breakfast. When grapefruit blocks drug metabolism, the drug accumulates in the bloodstream to toxic levels. Regular grapefruit consumption while taking medication causes the drug to accumulate, producing effects much larger than the prescribed dose intended. Grapefruit may be considered for afternoon or evening cortisol management when elevation is needed, but rebound-management concerns apply.